# YUSIMRY

NDC: 70114-210
Generic name: adalimumab-aqvh
Labeler / Manufacturer: Coherus BioSciences Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230701

FDA application: BLA761216

## Active ingredients

- ADALIMUMAB: 40 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70114-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70114-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd0e7af2-7704-49ce-bde9-f645294b6788